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Ion mobility spectrometry is an analytical technique that separates gaseous ions 
depending on their mobility in a gas filled cell under the influence of an electric field. 
More compact ions transit through the cell more easily than elongated ions of the same 
mass. Ions with a higher charge state also transit faster than those with lower charge 
states. When coupled to mass spectrometry, which separates ions according to their mass 
to charge ratios, the synergistic platform becomes a more reliable analytical technique, 
Ion mobility Mass Spectrometry (IM-MS), which can give an additional information of 
the samples being analyzed. More importantly, the ability to resolve structural isomers is 
a very pertinent aspect of this analytical technique. Ribonucleic acid, RNA is one of the 
two nucleic acids besides Deoxyribonucleic acid, DNA. DNA stores the genetic 
information of an organism while RNA transfers the genetic information from the DNA 
for protein synthesis.  There are various types of RNAs and most of them, including 
microRNAs have been reported to be biomarkers for various diseases including cancer. 
>55 % of the currently reported human microRNAs are isomeric.  
Various methods used to analyze microRNAs have their limitations, for mass 
spectrometry, co-elution from the column of isomeric microRNAs that have close 
physicochemical properties is a challenge to tandem mass spectrometry. This research 
focused on developing an ion mobility mass spectrometry-based method geared towards 
resolving isomeric RNA biomarkers. However, when using ion mobility, scientists are 
 
faced by lack of a universal calibrant which can be applied across platforms and inter-
laboratories. In addition, the instrument selected for this study has been reported widely 
in literature as causing ions to heat up in the ion mobility cell. The first project aimed at 
addressing the calibration limitation for ion mobility. To address this issue, we have used 
MALDI (Matrix Assisted Laser Desorption Ionization) matrices to develop a reference 
method that can potentially be applied across different platforms and in different 
laboratories using these matrices.  
The second project was aimed at investigating the Effects of different modes of 
operation on total internal energy of ions in traveling wave ion mobility mass 
spectrometry. We have compared the total internal energy of selected molecular ions as 
they transit through the Triwave ion mobility mass spectrometry platform by use of 
percentage dissociation of the ions in the two Collision Induced Dissociation (CID) cells 
in the instrument when operated in different modes that are available on the platform. 
These experiments have shed some new insights into the extent of ion heating in the 
instrument and will be helpful with a project related with the current research in our lab. 
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CHAPTER I 
INTRODUCTION 
 
 
1.0 Review of Literature 
1.0.1 Nucleic Acids 
 
Nucleic acids store and process genetic information in both prokaryotic and 
eukaryotic cells, thus the roles they play in cellular processes are vital. The central dogma 
of biology describes how the genetic information flows from a Deoxyribonucleic acid 
(DNA) sequence to protein which is the product. Ribonucleic acids (RNAs) is one of the 
other nucleic acids and the main role of RNA is to carry out the instructions encoded in 
the DNA for synthesis of proteins. To carry out these complex activities, there are various 
types of RNAs involved. Generally, the RNAs are grouped into coding and non-coding 
RNAs. Non-coding RNA is a functional RNA molecule transcribed from DNA but not 
translated into proteins. They include; lncRNA, miRNA, piRNA and siRNA. Their role is 
to regulate gene expression. The composition and sequence of canonical nucleotides in 
addition to their chemical modifications in RNA determine their structures as well as 
their functions
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Figure 1.1. Central Dogma of Basic Molecular Biology 
 
 
1.0.2 MicroRNAs 
 
MicroRNAs are short (18-25 nucleotides, figure 1) non-coding RNAs. They act as 
main regulators and play a major role in regulation of gene expression through either 
translational repression or cleavage of mRNA. Due to their roles in various cellular 
processes, they have been proven to be disease biomarkers for various diseases including 
cancer. Global profiling of microRNAs will assist in understanding how they carry out 
these important processes. Thus, having highly sensitive and selective detection methods 
will assist in extending the insight about their roles especially in human biological 
processes. 
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Figure 1.2. Distribution of Sequence Length of Reported Human MicroRNAs
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1.1 Challenges of Analyzing MicroRNAs 
 
There are two major challenges that are inherent with microRNAs analysis
 
1.1.1 Size
 
They are small in size in comparison to other RNAs, this comes with a challenge 
to most of the currently applied detection methods which depend on hybridization where 
a complementary labeled oligonucleotide probe hybridizes with the target microRNA 
molecule. Small hybridization probes ultimately demand low annealing temperatures 
which decreases the precision of the probe and thus promoting risks of cross-
hybridization. False positive is possible if selectivity is low especially if there is only one 
mismatch on the base sequence1 between targeted microRNAs and any other available 
microRNA in the sample. 
1.1.2 Low Abundance  
The concentration of microRNAs in a cell compared to other RNAs is low, 
reported to be 0.1%2. If isolation of microRNA is the goal, sample preparation and 
efficiency of the isolation method may limit the sensitivity of the assay. Due to this 
challenge, microRNA enrichment is needed and this lengthens the assay time.  
1.1.3 Isomerism 
According to one of our studies, the extent of human microRNAs isomerism is 
>55%. In addition, some pairs of microRNAs have only one mismatch in their nucleotide 
sequences. While close similarity in sequence is a challenge to hybridization-based 
detection methods, using mass spectrometry to analyze a mixture of microRNAs in a 
sample would prove challenging especially if, due to their similar physicochemical 
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characteristics, they co-elute from the LC column and will eventually be a challenge to 
analyze using mass spectrometry alone. 
1.2 Established Analytical Methods for MicroRNAs Detection 
The existing methods for microRNA detection can be grouped into three main 
approaches; PCR, Northern blotting and microarray. For all these methods, a transducer 
must be employed to translate hybridization of the complementary probe to the target 
microRNA in order for the binding to be picked up as a signal. These methods are briefly 
discussed here highlighting their limitations. 
1.2.1 Reverse Transcription Polymerase Chain Reaction Based Methods (RT-qPCR) 
PCR comes in handy when only minute amounts of microRNAs are generated 
from a sample. Complementary primer oligonucleotides are used to anneal and extend 
and thus amplify microRNAs in the sample3. Because of the short nature of the 
microRNAs, the primers must be short as well and this, as discussed earlier compromises 
the sensitivity and selectivity of the method.  
1.2.2 Northern Blotting 
Considered to be the gold standard for microRNA detection and validation, 
Northern blotting involves complementary labelled oligonucleotide probe immobilized 
on a nitrocellulose membrane wells4 These oligonucleotides have a signal transducer 
attached to them for signal generation upon hybridization with the target miRNA. The 
sample containing miRNAs is then added into these wells which is then washed to 
remove any un-hybridized material. The amount of signal generated from each well is 
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then measured to account for amount of miRNA present. The limitation inherent with 
hybridization techniques is a limitation to using this approach. 
1.2.3 Microarray 
Microarray is known to have a high throughput capability and involves a 
complementary DNA probe hybridization to a target miRNA. However, instead of 
labeling the probe, the target microRNA is labelled. This limits hybridization of the target 
microRNA to an immobilized spot thus making it easy to visualize the process. In 
addition to hybridization based limitation, microarray is considered to be semi-
quantitatively and is limited to comparing expression levels of miRNAs between 
different samples requiring another method for validation.  Since all the miRNAs are 
analyzed in parallel, it requires the same hybridization conditions, microRNAs have 
come with a relatively wide range of Tm, it is usually problematic to design probes which 
will match this requirement5. Since microarray requires minimal volume, they are known 
to have low sensitivity.  
1.2.4 Next-Generation Sequencing (NGS) 
This is one of the latest detection methods for microRNAs and comes with its 
own advantages and limitations. It involves ligating sequence adapters to size selected 
RNA molecules followed by reverse transcription to cDNA. The cDNA is profiled for 
microRNA fragments with ligated adapter for further sequencing. Since it does not 
require prior knowledge of sequences, it comes with the potential of discovering novel 
miRNAs. Also, it generates a huge amount of data depending on the sample. As a 
downside, high level of computation and validation is required in distinguishing between 
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real data and noise. NGS requires large amount of RNA sample to prepare the library. 
Sequence similarity of miRNAs poses to NGS a challenge when discriminating between 
miRNAs due to PCR and sequencing errors. The short nature of microRNAs and their 
variable length reduces the ability to accurately identify the border between the miRNA 
and the adaptor employed 6. 
As the technologies discussed above continues to be improved expanding the 
knowledge on mechanism and functions of microRNAs. There exists a common 
challenge to all of these methods; close similarity of sequences within microRNAs. As 
the potential for the methods evolve, a need to develop a method that will among other 
challenges address cross-hybridization will be necessary.   
1.3 RNA Modifications 
Modification of RNA is the chemical changes that occur in the composition of 
RNA molecules after synthesis. These changes have the potential to modify RNA 
function and/or stability.  
As of this writing, 170 different types of RNA modifications at specific locations 
mainly in their nucleobases or the ribose sugar have been reported7.  
1.3.1 Challenges in Structural Analysis of RNA 
The chemical changes on RNA molecules are usually facilitated by specific 
enzymes. Detecting and analyzing these changes in would help in understanding their 
biological functions. The following methods, are the most common applied in detection 
of RNA modifications 
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1.3.2 Reverse-Transcription Based Methods  
RNA templates of interest are transcribed in reverse to cDNA using reverse-
transcriptases. These cDNA fragments are then separated in gels. This method utilizes the 
blocking of the reverse transcriptase upon encountering a modification on the RNA 
template8. Among other limitations, this method cannot detect modifications that are 
close to the ends of the RNA molecule9. In addition, not all modifications can cause the 
reverse transcriptase to stop and therefore some of the modifications are lost or cannot be 
detected using this method. 
1.3.3 Chromatography Based Methods 
Liquid chromatography methods are used to identify modified nucleosides based 
on the differences in their chromatographic retention time compared to the canonical 
nucleosides. Thin layer chromatography is a relatively simple and simple cost-effective 
method suitable for small research laboratories. It is usually applied for shorter RNA 
molecules. Complete digestion using different nucleobases assists in building up of 5’-
monophosphate nucleosides or dinucleotide diphosphates maps which show localization 
of the modifications. Due to close physicochemical characteristics of modified fragments 
or even nucleosides, possibility of co-elution from the column exists.  
1.3.4 Next-Generation Sequencing  
NGS provides high throughput capability and opportunities for new applications, 
but the costs on its equipment’s reagents and data analysis may exceed the budgets of 
many research projects. More importantly, NGS is NOT capable of detecting majority of 
the chemical and enzymatic modifications on RNA molecules. 
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1.3.5 Mass Spectrometry Based Methods 
To address the issue on the detection of RNA modifications, an alternative 
method, namely liquid chromatography-mass spectrometry (LC-MS), is commonly used. 
RNA modifications would usually lead to changes in the molecular mass of RNA, except 
the isomerization of uridine, thus allowing the use of MS measurements to identify the 
type of RNA modification10, 11. However, some specific RNA modifications could occur 
at different positions within the same nucleotide, for example N6-methyladenosine (m6A) 
and N1-methyladenosine (m1A). In addition, Adenosine can also be methylated at 
positions 2 and 8 resulting in m2A and m8A respectively12. It is important to note that all 
these modifications are isobaric. Thus, the detection of isobaric RNA modifications 
represents significant analytical challenge. Thus, distribution of these methylations in 
RNA is poorly understood. MS measurement cannot differentiate these modifications. To 
overcome this challenge, Jaffrey and his co-workers have recently reported the use of 
anti-m6A antibody in detecting m6A in the whole transcriptome13. It is important to note 
that m6A antibody also recognizes also recognize N6,2-O-dimethyladenosine (m6Am) 
and can result in misidentification14, 15. The method involves fragmentation of RNAs to 
sizes between 50 and 100 nucleotides that may or may not consist of methylated RNA. 
Following the recognition of m6A, the immunoprecipitating of the fragments that 
consist of m6A was carried out. By using NGS, the approximate position of m6A within a 
RNA molecule was determined. This method lacks the ability to generate a signal that 
corresponds to the direct detection of m6A, which is often one of the ways to accurately 
differentiate m6A from the other possible RNA methylation. More importantly, this 
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method does not pinpoint the exact location of the modified nucleotide, which is required 
for studying the subsequent effects of having the RNA modification. Another drawback 
of this method may include the fragmentation of larger RNAs into shorter fragments may 
generate isomeric RNA fragments, i.e. same size and identical nucleotide composition, 
and poses another challenge to the MS measurements.  
1.4 Purpose of the Study  
The purpose of this study is to develop a new an ion mobility mass spectrometry-
based method that can address the analytical challenge in isomeric RNA identification  
1.5. Hypothesis and Specific Aims 
1.5.1 Hypothesis  
We hypothesize that ion mobility mass spectrometry can facilitate the 
identification and differentiation of isomeric modified and unmodified RNA biomarkers 
1.5.2 Specific Aim 1 
To utilize intrinsic MALDI matrix cluster ions that coexist with samples as 
internal reference in Ion mobility Mass Spectrometry 
1.5.3 Specific Aim 2 
To investigate the extent of cooling/heating of ions in Triwave ion mobility mass 
spectrometry 
1.5.4 Specific Aim 3 
Establish the extent of Isomerism in human microRNA disease biomarkers and 
the inherent analytical challenges 
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1.6 Significance of the Study 
RNA has a crucial role of regulating cellular processes. For RNA to effectively 
carry out this function in a cellular milieu composed of DNA and proteins, modifications, 
which sculpts its niche and entrenches its vital role is a necessity. These modifications 
have been associated with human diseases, for instance, in human, the discovery of fat 
mass and obesity associated gene (FTO), which oxidatively demethylates m6A in vitro 
established a link between methylation of Adenosine to human health. FTO is highly 
expressed in the brains and located within the hypothalamus, an important part of the 
brain dedicated to metabolism. Genome wide association studies have found a strong 
association between FTO and risk of diabetes and obesity in multiple human populations. 
Unswerving from human data, growth impedance, altered body weight and increased 
calamitous results were observed in mice upon deletion of FTO gene. Identification and 
localization of these vital modifications are lost when using high throughput sequencing 
methods where reverse transcription of RNA into complementary cDNA is performed. 
The alternative to these methods are enzymatic or chemical hydrolysis of the 
RNA which obliterates sequence information of the RNA of interest not to mention the 
laborious labelling that comes with these methods. Furthermore, none of these methods 
could identify and locate both modifications simultaneously. Thus, developing a method 
that will locate the modification site and discriminate between the modification type and 
location will assist in understanding effects of these modifications at specific genes. In 
addition, via one of our ongoing research projects that focuses on the detection of 
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unmodified microRNA, we realized that there is an unexpectedly high percentage of 
isomeric microRNA within the human body.   
Isomeric microRNAs are defined as having the same number of nucleotides and 
their nucleotide composition are identical. We coined the term SimiR (Structural isomers 
of microRNAs). There are currently over 2500 human microRNAs reported. More than 
55% of these are composed of sequence isomers. Isomerism of such short sequences 
poses an insurmountable analytical challenge from the perspective of MS measurements 
since isomeric microRNAs are indistinguishable by their molecular masses alone, unless 
tandem MS measurements are used, and complete sequence coverage can be achieved. 
Some isomeric microRNAs could also have a high degree of sequence similarities.  
This represents a challenge to the LC separation prior to the MS measurements. In 
other words, isomeric microRNA could be co-eluted from the LC column. Isomeric 
microRNAs are encoded by different genes. Some of them are associated separately to 
the same disease. Hence, it is important to come up with an analytical capability to 
distinguish isomeric microRNA in the LC-MS methods. Eiichiro et.al.16 employed Ion 
mobility mass spectrometry to resolve two isomeric microRNAs which proved futile. In 
this study we planned to apply both ion mobility and mass spectrometry to come up with 
a novel method to resolve isomeric RNA. To achieve this goal, we first tackled two 
underlying challenges that come with the technique and instrument employed to this end. 
First, we developed a method which uses intrinsic matrix cluster ions, reported as 
interfering with the low mass range in mass spectrometry, as internal reference for ion 
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mobility.  This method has a potential of being applied across different platforms and 
laboratories as long as MALDI matrices are co-crystalized with the samples of interest. 
The instrument used in this study, Synapt G2, has been reported widely in 
literature to cause ion heating in the ion mobility cell. Since this was the first time our 
research group was using the instrument, we embarked on investigating the extent of 
heating and the effect it would have on our studies. We compared the total internal 
energy of the ions as they transit through the platform using the percentage of 
dissociation of the ions in the two CID cells and the two modes operation available in the 
instrument. The findings reported and discussed in this dissertation (Chapter four) will 
assist our research group in achieving the goals of a related research project
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CHAPTER II 
ION MOBILITY MASS SPECTROMETRY 
 
 
2.1 Ion Mobility Spectrometry 
Primers for the gene prpC Ion mobility spectrometry is a technique employed in 
separation of chemical substances as gas phase ions based on their transit in a gas filled 
compartment under influence of an electric field (E, in units of V/cm). When in presence 
of an electric field, gas phase ions attain a drift velocity, Vd (cm/sec) which is 
proportional to the strength of the electric field thereof.  Thus, Vd =KE 
Where K is the mobility constant, E is the electric field strength and of course Vd is the 
ions drift velocity. Acceleration of the ion by the electric field, E is proportional to the 
charge of the ion, e. Since elongated ions experience more deceleration than compact 
ions, the mobility of the ion is inversely proportional to both N (gas number density, 
(Number of particles of the gas present in a given volume), and the rotationally averaged 
collision cross section of the ion,. In presence of a buffer gas, the gaseous ions mobility 
is decelerated by the collision of the buffer gas molecules. Thus, the ions velocity is 
inversely proportional to the gas number density, N
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With a light buffer gas e.g. Helium, detailed structural information of the ions can 
be gathered by applying an equation that quantifies the mobility of the ions, K with 
respect to all the preceding quantities usually referred to as, Mason-Schamp equation.
 Thus 
 
 
                                            equation 1 
 
   
Where K0 is the reduced mobility measured at standard conditions, E is the elementary 
charge, Z the charge state of the ion,  the reduced mass of the buffer gas with (mass M) 
and the ion with (mass m) i.e. μ=Mm/(M+m), kB is the Boltzmann constant and T is the 
buffer gas temperature 
Since an ion mobility analyzer requires low power supply, is light in weight and is 
compact in size, this has enabled its wide application as handheld devices in the field and 
on-site. It’s high sensitivity in a wide range of conditions has played an unprecedented 
role in chemical weapons monitoring within the military and application in commercial 
aviation in detection of explosives. The utility of IM is predicated by the ability of 
chemical substances ease of ionization. The ions hit the detector, are neutralized and the 
current generated is amplified then Fourier transferred to a read-back which is a mobility 
spectrum 
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2.2 History of Ion Mobility 
The history of ion mobility can be traced back to when Ernest Rutherford ionized 
molecules by x-ray, 1897 and later characterized them using their mobilities, in 1899. 
This was followed later by theoretical studies on ion mobility by Mason & Schamp in 
1958 and McDaniel in 1964 which laid the foundation of IM-MS studies as we know it 
today.       
2.3 Ion Mobility Mass Spectrometry 
When ion mobility spectrometry is hyphenated with mass spectrometry, hereby 
referred to as IM-MS, an additional level of information is gained which breeds a 
synergistic technique capable of discriminating ions based on the mass to charge ratio in 
addition to the topology of the ions which has enabled it to gain traction in separation of 
complex samples in metabolomics17-19 ,glycomics20 anomers using ion mobility mass and 
proteomics21, 22. This hybrid of complementary analytical techniques has seen a 
significant progress both in technological advances and in a wide range of pioneering 
applications. It has pushed the limits of analytical techniques and enabled sufficient 
delivery of comprehensive sample information. This is evidenced by the increase in the 
number of publications with ion mobility mass spectrometry as the analytical technique 
(Figure 2.2). A critical advantage of IM-MS is the ability to discriminate structurally 
isomeric samples22-25 (Figure 2. 1 ) and polymeric isomers26. 
 It is predictable that; this technique will continue to gain ground in 
multidisciplinary areas of science. A variety of IM designs have been described in 
literature which includes; Drift time27, 28 Differential29, Triwave30 and Trapped ion 
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mobility spectrometry31. The interfacing of these ion mobility spectrometers with 
different types of mass analyzers i.e. time of flight, ion Trap, ion Cyclotron, magnetic 
sector and the quadrupole has made it possible to come up with several IM-MS 
configurations. Traveling wave based ion mobility (TWIMS) is one of the latest novel ion 
mobility technologies32 and consists of stacked ring electrodes with adjacent rings having 
opposite phases of RF voltages which radially confines the ions within the device while a 
DC potential is applied to a pair of adjacent rings sequentially and in pulses, resulting 
into a traveling wave where the ions surf the wave with some falling off while others 
riding with the wave, helping in separation of the ions according to their mobility. The 
data reported in this study was carried out in a Synapt G233, a Waters instrument using
 triwave technology. 
 
 
 
 
Figure 2.1. Simplified View of what Ion Mobility Separation of Isomers Could Achieve 
 
 
The figure below is an evidence of how this progress has energized research in 
varied fields. Data was generated using Web of Science, SCI-expanded between 1992
and 2017, search terms ‘ion mobility’ and ‘mass spectrometry’. 
Ion Mobility 
mixture of two isomeric 
samples A and B 
Drift time (ms) 
A B
A
B
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Figure 2.2. Number of Peer-Reviewed Papers Published Annually (to end of 2017) 
Combining Ion Mobility and Mass Spectrometry  
 
 
2.4 Commercially Available Ion Mobility Instruments  
Different ion mobility technologies have been developed over time with different 
modes of operation and design. The choice of the type of instrument to apply in analyzing 
one’s sample will depend on availability of funds and the analytical needs of the sample. 
Although there are various commercially available mass spectrometry instruments to 
choose from, the number of ion mobility mass spectrometry commercially available do 
not match up. This could be because the technology and its application is picking up and 
we could see a surge in the number of these instruments in the near future.   
2.5 Triwave Ion Mobility Mass Spectrometry Instruments  
Traveling wave technology based ion mobility instrument, Synapt T-Wave 
SYNAPT G2 HDMS (Waters, U.K.) by Waters was chosen for the study. The unique 
layout for the components of this instrument made it a great choice for our work. It has 
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two collision cells, one immediately before the IMS cell, the Trap, and the other 
immediately after IMS called the Transfer cell. This provides us with the ability to 
perform two CID or MS/MS (Collision Induced Dissociation) processes either before or 
after separation in the IMS cell or in both cells. It is also reported to have a high duty 
cycle34. In addition, it has switchable ionization sources i.e. MALDI and ESI at the front. 
However, one of its downside as widely reported in the literature is that ion heating 
occurs in the IMS cell. The effect of this heating on CID experiments, to our knowledge, 
has not been reported
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Figure 2.3. The Synapt G2 Schematic Diagram 
 
 
2.6 Ion Mobility Mass Spectrometry Calibration 
 
Like the conventional MS techniques, success on IM-MS measurements relies on 
the calibration of both drift time and mass. Unlike in drift tube ion mobility instruments, 
the golden standard for calibration of traveling wave ion mobility instruments requires 
experimentally determined collision cross section (CCS) values of well-known calibrants 
as references32, 35, 36. The relationship between CCS and arrival time distribution (tD) is a 
well-established theoretical and practical underpinning37.  Use of a wide variety of 
calibrants with known collision cross section has been reported38-40. These calibrants 
must meet specific standards including; their CCS values must be accurately reported and 
published, their size should cover the range of the analytes of interest and they should be 
rigid enough to withstand potentially harsh sample preparation and experimental 
conditions e.g. temperature, pressure, humidity and the nature of the drift gas which 
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could change their conformations in the process. Effects of these conditions on calibrants 
are minimal when analysis is done under the same conditions and on the same 
instruments.  However, reproducibility is a challenge when experiments are performed 
across laboratories and in disparate instruments. For the users of travelling wave ion 
mobility instruments which includes the Synapt series, various researchers have reported 
a variety of calibrants for specific analytes. For instance, Julien De Winter et.al41. have 
developed synthetic polymers for calibrating the Synapt G2 in positive ion mode only. 
Structurally different calibrants used usually results in higher error values in CCS 
measurements42.  All these reports are born of the fact that there lacks a single calibrant 
which can be employed for analysis of a wide range of analytes regardless of their 
structural differences. Thus, there is a lack of consensus on the choice of universally 
accepted calibrants among the IM-MS scientists.  
2.7 Conclusion 
Commercially available Triwave ion mobility mass spectrometry instrument, 
Synapt G2 would be a good fit to complete our studies. This is because of the 
instrument’s unique layout that will assist us in combining MS/MS with ion mobility 
separation. However, a common challenge with ion mobility calibration exists. We 
endeavored to tackle the calibration challenge that would set a pace for our studies on 
isomeric modified/unmodified RNA molecules.          
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CHAPTER III 
MALDI MATRIX CLUSTER IONS: INTERNAL REFERENCE IN ION 
 
MOBILITY 
 
 
3.1 Introduction  
 
 Matrix Assisted Laser Desorption Ionization (MALDI) is an ionization technique 
widely applied in analysis of both biomolecules and synthetic polymers. A specific 
MALDI matrix selected to assist in ionizing the analyte of interest is desorbed in a plume, 
usually in-vacuo and in the process, the analyte is ionized producing predominantly 
singly charged ions. MALDI matrix cluster ions are known to interfere with the 
interpretation of the analyte peaks in the low mass range especially below 1000 m/z. 
When MALDI is combined with ion mobility, its application widens and a variety of 
analytes can be qualitatively and quantitatively analyzed. Analytes trendlines are usually 
displayed on the drift time vs m/z plots according to their charge states and class of 
molecules. Lack of a universal calibrant that can be used inter-instruments and inter-
laboratories in ion mobility has been a lingering challenge. We used MALDI matrix 
cluster ions mobility trendline shifts to correctly predict the drift times of PEG and AIP 
upon changing TWIMS parameters i.e. wave velocity and wave heights. PEG was chosen 
for its intrinsic polydispersity characteristic while AIP was chosen as a suitable 
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biopolymer representative. We prove that this dependence of the trendline shift with 
changes in ion mobility parameters can be used as internal reference in MALDI ion 
mobility mass spectrometry experiments 
3.2 MALDI Ionization 
Matrix assisted laser desorption ionization (MALDI)43 is among the most 
commonly used soft ionization techniques which was developed decades ago and it’s 
broad application has been successfully demonstrated44-47. The technique involves co-
crystallization of the sample with the matrix (Conventionally weak solid organic acids 
e.g. CHCA, DHB, SA and CHCA which exhibit a strong resonance ultraviolet absorbing 
capability at the laser wavelength used), whose role is to strongly absorb the laser UV 
energy and ionize the sample through either donation of proton or accepting of proton 
from the analyte in positive and negative ionization modes respectively. A pulsed laser is 
used to generate the ions. Generation of ions in pulsed mode has made it compatible with 
time-of-flight (TOF) mass analyzer. (Figure 3.
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Figure 3.1. MALDI Ionization Process 
 
 
Due to its advantages of requiring relatively low sample for analysis, higher 
sensitivity, high sample throughput, high tolerance of salts, rapid analysis and non-
complex sample preparation process MALDI has become a great technique and has been 
applied in different type of samples analysis. Additionally, MALDI has an advantage of 
producing predominantly singly charged parent ions making it a suitable technique for 
analyzing a wide range of complex samples such as those found in metabolomics48 and 
proteomics.49 Although detailed mechanism of how analyte ions are generated in MALDI 
still remains controversial, there are models that propose the analyte ionization process. 
They include; photochemical ionization50 which suggests that collision of analyte 
molecules with matrix ions in the gas phase brings about protonation or deprotonation of 
the analyte. The other one is the cluster ionization51 which proposes that strong UV 
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absorption by the matrix molecules causes ionization of the analyte upon desorption Chen 
et.al.44 lately proposed energy transfer induced disproportionation mechanism where 
pseudo proton transfer happens during the co-crystallization of the matrix and analyte.  
3.3. MALDI Matrix Cluster Ions 
Accumulation of excitation energy in the matrix induces emission of explosive 
cluster which leads to formation of numerous intense cluster ions. These cluster ions are 
usually associated with the complication of analyzing analyte ions in the low m/z region 
~1000 Da due to their interference with the analyte ions52. This interference affects the 
spectral quality and data interpretation thus increasing the detection limits compared to 
other ionization techniques like ESI. Since MALDI matrix cluster peaks which depends 
on the type of analyte, strength of the laser and amount of salt and metal adducts present 
are not reproducible and their appearance and relative intensities not predictable, the 
phenomenon makes some researchers shy away from using MALDI especially when the 
analytes fall in the low m/z region. However, there are various methods reported to 
expand the use of MALDI-MS in analyzing low mass range analytes and are discussed in 
detail here52-54 
3.4 MALDI Ion Mobility  
Due to the ability of generating ions in pulses, MALDI ionization source coupled 
with ion mobility mass spectrometry technique has seen its application broaden. 
Researchers have been able to directly profile and image tissues to elucidate structures of 
various analytes and map their distribution.55 The incorporation of time-of-flight mass 
analyzers into commercially available instruments has facilitated this growth in 
    26     
application.56 Mass-mobility correlation lines hereby referred to as Trendlines are known 
to form according to both the class of molecular structures of the analytes and the charge 
states of the analytes.36 These trendlines have been observed regardless of the instrument 
used in the analysis and both in the ESI or MALDI experiments. Since in MALDI, the 
dominant ions generated are usually singly charged the trend lines are easy to locate on 
the 2 D plot.  
The focus of this research project is to explore the use of MALDI matrix cluster 
ions trendlines that are intrinsically generated during the matrix-assisted laser 
desorption/ionization (MALDI) ionization process as internal references for measuring 
the drift time in IM-MS analysis.  
 
3.5 Experimental  
3.5.1 Materials and Methods  
3.5.1.1 Preparation of MALDI Matrices  
When choosing a MALDI matrix, it is common practice to have a matrix whose  
laser wavelength absorption is high enough to facilitate ionization of the sample being 
investigated. Among other characteristics that must be met for a MALDI matrix to result 
in a successful MALDI experiment includes miscibility1 with the analyte and solubility in 
the solvent of choice. For this study we investigated four widely used MALDI matrices 
chosen as representatives for all matrices i.e. CHCA, 3-HPA, DHB and SA. MALDI 
matrices that were used in this study were prepared using standard procedures that are 
available in literature. CHCA was prepared by dissolving 20.0 mg of CHCA in 1.0 mL of  
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50% ACN with 0.1% TFA and was stored away from light. 3-HPA was prepared by 
dissolving 35.0 mg of 3-HPA and 8.8 mg of ammonium citrate dibasic in 1.0 mL of 10 % 
CAN with 0.1% TFA and filtered as above. 2,5 DHB was prepared by dissolving 30 mg 
DHB in 30% acetonitrile and 0.1% trifluoro acetic acid. (Krause et al. 1999). Sinapinic 
acid (SA) was prepared by dissolving 20 mg of SA in 50% acetonitrile and 0.1% trifluoro 
acetic acid. The matrix solutions were vortexed for 1-2 minutes, filtered using 0.22-
micron Non-sterile low protein binding Durapole (PDF) syringe driven filter membrane 
for fine particle removal and stored at −20 °C 
3.5.2 Spotting  
In each experiment, the matrix was mixed with equal volumes of the sample 
solution and a volume of ~0.2 µL pipetted on the wells of the dried droplet method used 
to dry the matrix and samples   
3.5.3 Model Molecules  
For prove of concept, two model molecules, Auto Inducing peptide (AIP), of 
molecular formula C43H59N8O13S2 and monoisotopic mass 960.3721 Da to represent 
biomolecules. Figure. 3.2.a (Auto inducing peptide (AIP) standard 
C43H59N8O13S2=960.3721 Da) and Figure 3.2.b (Polyethylene glycol (PEG 1000))
 were used. 
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Figure 3.2.a. AIP Standard                                                      Figure 3.2.b. PEG 1000 
 
 
3.5.4 Sample Preparation  
Since MALDI as an ionization technique is widely used in both biomolecules and 
synthetic polymers, the molecular probe ions used in this study were selected with that 
fact in mind. The first model molecule, AIP-I, (Auto inducing peptide) (≥95% purity by 
HPLC) was obtained from AnaSpec Inc. (Fremont, CA) as a powder and was dissolved in 
50:50 v/v acetonitrile: water to make 100 uM stock solutions and then diluted to 1 uM 
using 50 % acetonitrile with 0.1% TFA.  
PEG (Polyethylene glycol 1000, Bioultra) was bought from Sigma Aldrich (Louis, MO) 
and was prepared by mixing 10 μL of PEG 1,000 with 2 mg/ mL of sodium iodide in 50 
% ACN as outlined for calibration of the Waters Synapt G2 instrument by the 
manufacturer. 
All the data was acquired using a hybrid Q-TWIMS-time-of-flight (TOF) MS 
(Synapt G2 High Definition Mass Spectrometer; Waters, Milford, MA, USA) equipped 
with interchangeable MALDI and ESI sources. The instrument operates in two modes i.e. 
T-Mode (TOF mode) where it separates ions according to their mass to charge ratio and 
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in M-Mode (Mobility TOF mode) where it separates ions according to size, shape and 
charge in addition to mass to charge ratio. The TOF analyzer in this instrument can be 
operated in three modes i.e. Sensitivity mode, where the ions travel in the TOF analyzer 
through a ‘V’ optics settings, Resolution mode which also have the ions travel through a 
‘V’ optics settings and High-Resolution mode where the ions transit through a ‘W’ optics 
settings. The data reported here was collected in the resolution mode. The instrument was 
operated in the ion mobility mode with most parameter settings at the default i.e. Gas 
flow; Trap gas flow of 2.0 mL/Hr., helium gas flow at 180 mL/min and nitrogen gas at 90 
mL/min. The HM resolution (sets the width of the quad transmission) was set at 4.4 as 
recommended by the manufacturer for MALDI experiments. For this study the wave 
velocity and wave height whose change affects the transit of ions according to the need of 
the experiment. 
3.6 Results and Discussions 
3.6.1 Spectrum Acquisition 
3.6.1.1 MALDI Matrices  
For prove of concept, all the MALDI matrices data was acquired both in positive 
(figure 1 a-d) and negative polarities at a consistent scan time of 1.0 second and 
acquisition time of 0.5 minutes for each experiment. The mass range was set at between 
50 to 1000 m/z. The laser was set at an energy of 350 nm and data was acquired by 
manually moving the laser across the selected spot on the target MALDI plate to 
maximize ablation of the sweet spots with the laser beam on the unevenly spread co-
crystalized sample and matrix mixture. All the MALDI matrices displayed mobility 
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trendline which shifted similarly with changes in ion mobility parameters. CHCA matrix 
was randomly chosen as a representative matrix for the studies that follow, in addition, 
positive polarity was employed in all data reported here.  To reduce the noise on the 
mobility trendline and to easily detect sample and matrix cluster ions signals, the 
intensity threshold was reduced to between 30% minimum and 100% maximum using the
 driftscope software provided by Waters.  
 
 
 
 
Figure 3.3.a to d. DriftScope Plots (Trendlines) of Different MALDI Matrices used in the 
Current Study. 
 
 
Shift of the matrix cluster ions Mobility Trendline with change in parameter 
settings. To adjust the transit time of the ions in the traveling wave ion mobility cell, i.e. 
improve the separation of ions, there are two parameters amenable to adjustment i.e. 
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either the wave height or the wave velocity. To investigate the behavior of the trendline 
upon changing the parameters, wave velocity was changed from 650 m/s to 850 m/s and a 
shift of the trendline increasing the drift time of the matrix cluster ions thereof was 
observed (Figure 3.4. a. and b.)  
 
 
 
 
Figure.3.4. CHCA Matrix Trendline at Wave Velocities a. 650 m/s and b.1050 m/s  
 
 
3.7 Linearity of the Mobility Trendline 
To investigate the linearity of the trendline, drift times for selected MALDI 
matrix cluster ions mass peaks which showed consistency in intensity and accuracy 
across several experiments were acquired from their respective mobilograms and used to 
plot a reference curve. Automatic peak detection capability in the Driftscope software 
was used to transfer the drift times for these peaks to MassLynx, a software for analyzing 
mass spectrometry data. This enabled the selected peaks to be distinguished in the 
Driftscope, (a software which depicts mobility data in a 2 D plot with drift time vs m/z 
values and the intensity of the ions shown by varying shades of colors) figure 4.  
Data was acquired by performing the experiment for each wave velocity three times  
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starting with the default; 650 m/s and then increasing to 850 m/s while keeping the wave 
height constant at the default setting 40 V.  
 
 
 
 
Figure 3.5. CHCA MALDI Matrix Cluster Ions Trendline with the Arrows Showing 
Selected Mass Peaks used for Generating the Reference Curve 
 
 
A table of the m/z values of the selected matrix cluster ions mass peaks, average 
drift times at 650 m/s and 850 m/s and the standard deviation (Table 3.1) was used to plot 
a reference curve (for figure 5). The linearity of the curve was confirmed with the R2 
value, i.e.  .9935  
 
 
Table 3.1. Average Drift Times for Selected m/z Values Cluster Ions at Wave Velocities
 650 m/s and 850 m/s  
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Figure 3.6. Average Drift Time for Selected m/z Values for CHCA Matrix Cluster Ions in 
Both Wave Velocities i.e. 650 m/s and 850 m/s  
 
 
3.8 MALDI Matrix Co-crystalized with Model Molecules 
After testing the effect of changing wave velocity on the shift of the matrix cluster 
ions trendline, Auto Inducing peptide (AIP) was co-crystalized with CHCA matrix to 
investigate the effect of the trendline shift on the drift time of the sample molecular ion. 
To achieve this goal, both wave velocity and wave height were adjusted, and the 
drift time of AIP signal monitored. 
3.9 Shift of the Trend Line with the AIP Signal 
Conditions in the MALDI source, trap and transfer TWAVE cells were kept 
constant while the wave velocity and wave height in the ion mobility cell were changed 
systematically and the data acquired for each experiment. Since the goal was to 
investigate the drift time of the sample ion’s signal with respect to the MALDI matrix 
cluster ions trendline, AIP was used since it displayed one discernable signal i.e. at the 
m/z value of 961 along the trendline after the front-end parameters of the instrument were 
optimized to minimize in-source fragmentation. The matrix cluster ions trendline shifted 
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together with the AIP signal with each change of the parameters. For instance, when the 
wave velocity was increased from the default settings i.e. 650 m/s to 850 m/s, the drift 
time for AIP changed from 8.6 ms (Figure 6 a.) to 11.3 ms (Figure 6 b) and, upon 
changing the wave heights from the default setting, 40 v (8.6 ms) Figure 6 c. the drift 
time changed significantly when the wave height was adjusted to 30 v (14.8 ms), Figure
 6d. 
 
 
 
 
Figure 3.7.a. MALDI Matrix Ions Trendline for Wave Velocity 650 m/s 
 
 
 
 
Figure 3.7.b. MALDI Matrix Ions Trendline for Wave Velocity 850 m/s 
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Figure 3.7.c. MALDI Matrix Ions Trendline for Wave Height 40 V 
 
 
 
 
Figure 3.7.d. MALDI Matrix Ions Trendline for Wave Height 30 V  
 
 
3.9.1 ESI IMS   
A similar experiment was carried out in ESI mode with the AIP standard. With all 
other parameters remaining the same apart from the ionization mode and with 
optimization to decrease in-source fragmentation, the wave velocity and wave height 
were varied. The results indicate that the drift time of the AIP signal shifted in the same 
proportion as in MALDI (figure 3.8 a and b).  
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Figure 3.8.a. AIP Signal at Wave Velocity 650 m/s in ESI Mode 
 
 
 
 
Figure 3.8.b. AIP Signal at Wave Velocity 650 m/s in ESI Mode 
 
 
3.9.2 Internal Reference Curves 
After observing that the shift of the trend line upon changing the wave velocity 
and wave heights happens with the sample ion signal, three different experiments using 
the same CHCA MALDI matrix stock solution at wave velocity 650 m/s and wave height 
40 v were performed from the same target plate to get the respective drift times for the 
five selected MALDI matrix cluster ions mass peaks. The average drift times were used 
to plot a reference curve whose R2 value was 0.9999 (Figure 3.9).  
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Figure 3.9. CHCA MALDI Matrix Cluster Ions Reference Curve from the Drift Time of 
the Selected Matrix Cluster Ions Mass Peaks at Default Settings. 
 
 
 
 
Figure 3.9.a. CHCA MALDI Matrix Cluster Ions Reference Curve Wave Velocity of 1250 
m/s and Wave Height 40 V 
 
 
3.9.3 Using Internal Reference Curve to Predict Drift Times for AIP 
To characterize the applicability of the reference curve in predicting the drift 
times for sample molecular ions, experiments were repeated with MALDI matrix co-
crystalized with the respective samples. For a start, the parameters were set at default 
settings i.e. wave velocity of 650 m/s and a wave height of 40 v. For AIP, upon acquiring 
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the mass spectrum for the sample/ matrix mixture, the drift times for the AIP were 
directly read from the m/z extracted mobilograms and the equation for the reference 
curve used to predict the drift time of the sample (calculated value). To establish the 
reproducibility of these approach, each analysis was repeated three times in different days 
and without changing the parameters, target plate, the sample or the matrix solution. The 
percentage error for all the trials were found to be >1.5 as shown in table 3.2  
 
 
Table 3.2. Application of CHCA Matrix Cluster Ions Reference Curve on AIP Sample 
Wave Velocity 650 m/s and Wave Height 40 V 
 
 
 
 
Table 3.3. Application of CHCA Matrix Cluster Ions Reference Curve on AIP at Wave 
Velocity 850 m/s and Wave Height 40 V 
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Similar reference curves for different wave velocities i.e. 850 and 1250 m/s were 
tested and the percentage error for drift time prediction of the AIP was found to be 0.18% 
for wave velocities 650 m/s and 1250 m/s.   
3.9.4 Using Internal Reference Curve to Predict Drift Times for a Polydisperse 
Sample 
To validate our reference curve, a different molecular ion in structure from AIP 
was employed. PEG 1000 was chosen due to its intrinsic polydispersity thus the ability to 
offer numerous ions covering a broad mass range and a large m/z window to test the 
reproducibility of the reference curve. In addition, PEG 1000 ions are reported to 
maintain their conformations amidst instrumental conditions in an experiment using the 
same instrument.40 Selected m/z values within the CHCA matrix cluster ions mass range 
and outside the matrix range were used to validate our results with AIP sample. 
Extraction of the drift times for the selected m/z ions was done as previously explained 
and the percentage error calculated. The average percentage error for all the ions was 
found to be 1.92 and all the ions had the percentage error < 4% (Table 3.5). 
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Table 3.4. Application of CHCA Reference Curve with PEG Sample, at Default Velocity 
650 m/s and Height 40 V 
 
 
 
 
3.9.5 Conclusion 
The goal of this study was to use the intrinsic co-crystalized matrix ions as 
internal reference in ion mobility. Based on the comparison between calculated and 
measured drift times using the reference curves obtained from selected matrix cluster ions 
drift times, we have demonstrated that intrinsic MALDI matrix cluster ions can be 
applied in predicting with relatively high accuracy the respective analyte ions drift times 
regardless of the parameter changes. Indeed, the percentage error for both molecular 
model ions used in this study was found to be > 5%. For the proof of concept, travelling 
wave ion mobility instrument, Synapt G2 is used. However, the approach of using 
internal reference to improve the accuracy of IM-MS measurements can be applicable to 
other MALDI ion mobility mass spectrometry platforms. 
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CHAPTER IV 
EFFECTS OF DIFFERENT MODES OF OPERATIONS ON TOTAL INTERNAL
 ENERGY OF IONS IN TWIMS 
 
 
4.1 Introduction  
 
The demands for achieving higher accuracy to detect known or unknown analyte 
has and will always continue in many areas of scientific research. The same has occurred 
on improving the resolution of traveling wave ion mobility mass spectrometry to 
distinguish isobaric ions with very close collisional cross sections. This led to a 
successful launch of the second generation of a commercialized technology on traveling 
wave ion mobility spectroscopy. Besides the performance on resolving collisional cross 
section, the principle of traveling wave ion mobility as well as the unique instrumental 
design in the Waters Synapt G2 have drawn research interests to study the additional 
outcome from carrying out the ion mobility measurements. In this study, the use of a 
simple experimental approach to estimate the variation on the total internal energy of ions 
as a result of changing the setting of a specific parameter is demonstrated.
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The approach is based on carrying out a series of MS/MS experiments by 
sequentially increase the collision energy in the transfer cell after the ion mobility 
separation is completed. Thus, neither modification in the instrumentation nor any 
theoretical calculation for the ion energy is required. The results of using this approach 
do comply with the earlier reports on studying the effects of the same parameters. Based 
on the estimation by using this approach, the variation of ion energy could be more than 
10eV. The information on the variation of ion energy as a result of using different 
parameter settings can potentially be useful for setting up and/or interpreting the results 
of MS/MS experiments as well as avoiding any unwanted conformational change of 
larger molecular ions or ion dissociation when target ions are analyzed by using traveling 
wave ion mobility mass spectrometry 
4.1.1 Ion Mobility Mass Spectrometry 
The coupling of ion mobility spectrometry to mass spectrometry is considered as 
a game changer for molecular analysis. The ion mobility spectrometry can provide 
information on the mobility of ions in the gas phase, which depends on the mass, charge 
and shape of ions.  By combining with the information available from carrying out mass 
spectrometric measurements, it certainly helps to improve the accuracy on analyzing a 
variety of sample types17, 18. With the ability to distinguish ions with different shapes, the 
ion mobility spectrometry can be very useful for analyzing structural isomers, which 
could be co-eluted from a liquid chromatographic column and carry exactly the same 
molecular mass. Thus, the analysis of many isomers remains a challenge to the current 
approach of using liquid chromatograph mass spectrometry.  
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The ion mobility technology that has been successfully coupled to mass 
spectrometry include: drift tube27, 28, 37    , differential ion mobility or high-field 
asymmetric waveform ion mobility57, traveling wave30 and trapped ion mobility58. 
Among the commercialized platforms for ion mobility mass spectrometry (IM-MS), the 
Waters Synapt series which base on the traveling wave technology has a unique and most 
versatile instrumental design32-34. In the Waters Synapt IM-MS instrument, following a 
switchable ion source, the ions can be sorted out by a quadrupole mass filter before 
reaching to the setup for traveling wave ion mobility separation. To the best of our 
knowledge, the Waters Synapt is the only commercialized IM-MS platform that offers 
the ability to select specific molecular ions prior to the ion mobility separation. After the 
ions are transmitted across the traveling wave ion mobility cell, the accurate mass of ions 
is measured by an orthogonal time-of-flight mass analyzer. Within the setup for traveling 
wave ion mobility separation, it first starts with a trap cell whose primary function is to 
convert the continuous flow of ions from the quadrupole into batches of ions. Each batch 
of ions is then analyzed in the traveling wave ion mobility cell. Since the traveling wave 
operates under a higher gas pressure than the subsequent time-of-flight mass analyzer, 
there is a transfer cell at the end of the setup. The unique design of Water Synapt includes 
making both trap cell and transfer cell to be available for the dissociation of ions. In other 
words, there are two consecutive collisional induced dissociation (CID) cells, one before 
the ion mobility cell and one after the ion mobility cell.  
The drawback of the current ion mobility technology including the traveling wave 
technology are the lack of high resolving power to distinguish larger ions with similar 
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collisional cross sections and the poor yield of ion transmission. In the latter case, one of 
the possible contributing factors could be the heating of ions inside the ion mobility cell, 
which may lead to unintended ion dissociation. To address this issue for using the Waters 
Synapt IM-MS platform, several research groups have attempted to determine the thermal 
status of ions inside the ion mobility cell. For instance, De Pauw et.al. reported the use of 
p-methoxybenzylpyridinium as a thermometer ion to determine the vibrational effective 
temperature of ions.59 Whereas, Merenbloom et.al. reported using the dissociation of 
protonated leucine enkephalin dimer as a probe and theoretically calculate the effective 
temperature of ions in the ion mobility cell.60 Shvartsburg and Smith used the mobility of 
ions to estimate the range of temperature rise in the ion mobility cell.33  In this report, the 
use of a simple approach to estimate the variation on the total internal energy of ions is 
explored, which may result from using different settings of the key parameters in the 
traveling wave ion mobility mass spectrometry. 
4.2 Materials and Methods 
4.2.1 TWIMS Parameter Settings 
All experimental data was acquired using a Waters Synapt G2 high definition 
mass spectrometer (Waters, Milford, MA, USA) equipped with an ESI source. The 
instrument was calibrated with Leucine enkephalin for mass accuracy and polyalanine for 
ion mobility accuracy as recommended by the manufacturer. The sample was delivered 
by direct infusion at a flowrate of 10 μL/min. The instrument was operated under the 
mobility TOF mode. The source temperature was set 120oC, the desolvation temperature 
at 240oC, the cone gas flowrate was maintained at 50L/hr., and the desolvation gas 
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flowrate at 50L/hr. while the other ESI parameters were optimized for an effective ion 
transmission. Unless otherwise stated, the traveling wave ion mobility cell was operated 
under the default settings, which included a flow of Argon gas to the Trap and Transfer 
cell at 2mL/min, a flow of Helium gas to the Helium cell at 180mL/min, a flow of 
Nitrogen gas to the ion mobility cell at 90mL/min, wave height at 40V, and wave 
velocity at 650m/s). To minimize the fragmentation of ions in the ion mobility cell, IMS 
bias voltage was set at 3V. The TOF mass analyzer was operated under the resolution 
mode, and the negative ion mode was used. In each experiment, the signals obtained from 
the sample was acquired for 1 minute and at a scan time of 1 second. 
4.2.2 Adenosine 3-Monophosphate (AMP)  
The AMP ion at 346m/z was selected as the precursor ion. AMP was purchased as 
lyophilized powder with 99% purity (Sigma Aldrich, St. Louis, MO, USA) and was used 
without any further purification. A stock solution of 1 g/L was prepared by dissolving 
AMP in autoclaved deionized water and stored at -200C. Before the experiments, 10μM 
AMP was freshly prepared from the stock solution by using 50:50 H2O: MeOH as a 
diluent. For calculating the % dissociation of AMP precursor ion, the fragment ions of 
PO3
- at 79m/z, adenine at 134 m/z, and pentose phosphate at 211m/z were selected.  
The MS/MS spectrum of AMP was retrieved by integrating 1min time in the ion 
chromatogram. The ion counts for the precursor ion and the selected fragment ions were 
used to calculate the percentage of dissociation using the equation below.  
 
 
% dissociation =
F
P+F
                           equation 1 
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Where F is the sum of ion counts of selected fragment ions, and P is the ion count of 
remaining precursor ion (if any). 
4.3 Results and Discussion 
4.3.1 Using Different Wave Heights 
According to the instructions from Waters on using the Synapt G2 to differentiate 
isobaric ions with different molecular shapes, the key parameters for optimal separation 
of isobaric ions are the wave height and/or wave velocity in the traveling wave ion 
mobility cell. De Pauw and his associates had reported the vibrational effective 
temperature of ions in traveling wave ion mobility mass spectrometry was increased as a 
result of increasing wave height59. In this report, by allowing a specific precursor ion 
passing through the ion mobility cell in the mobility TOF mode and sequentially increase 
the collision energy in the Transfer cell, the extent of ion dissociation (% dissociation), 
which is the result of a typical MS/MS experiment, starts from barely detectable level to 
increase proportionally with the increasing collision energy being applied to the Transfer 
cell, and eventually levels off at 100% dissociation when excessive collision energy is
 used (Figure 4.1).  
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Figure 4.1. Effects of Varying the Setting of Wave Height in Voltage (V) in the Traveling 
Wave Ion Mobility Cell of Waters Synapt G2 
 
 
While the parameter settings remain unchanged except the wave height is 
decreased from the default setting at 40V, the % dissociation curve of the same precursor 
ion starts to shift towards the right-hand side in Figure 1, i.e. higher collision energy. This 
result does comply with the principle of ions surfing along the traveling voltage wave, 
thus experience the changes in the wave voltage.31 To ensure the positioning of the % 
dissociation curves in Figure 1 is reproducible, the same MS/MS measurements were 
repeated four times, and the coefficient of variation of % dissociation was calculated. The 
average coefficient of variation among the data points in a % dissociation curve was as 
low as 1.7%. Hence, the error bar of each data point is too small to be effectively shown 
in Figure 1. With the Transfer cell located right next to the exit of the ion mobility cell, 
the requirement for using higher collision energy in the Transfer cell to achieve the same 
level of ion dissociation represents the total internal energy of ions was lowered as a 
result of decreasing the wave height from 40V. In other words, there is a direct 
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proportional relationship between the total internal energy of ions and wave height. In 
this study, the total internal energy of ions is defined as the sum of all the rotational, 
vibrational, kinetic and potential energy of the ions. 
 Without making any changes in the instrumentation or applying any new 
theoretical calculations for the energy of ions, the results of using this rather simple 
approach to evaluate the ion energy do agree with De Pauw’s finding on the direct 
proportional relationship between vibrational effective temperature of ions and wave 
height. In comparison to a report from Williams, in which the effective temperature of 
ions was measured, the approach in this study uses a precursor ion that is more thermally 
stable, thus the ion dissociation does not occur until the ions reach the Transfer cell.60 
Also, the complete dissociation curve is acquired and compared with another dissociation 
curve. As indicated above, no additional drift time measurement is required to estimate 
the variation on the total internal energy of ions.  
Based on the same concept on interpreting the results in Figure 1, the extents of 
variation on the total internal energy of ions that result from changing the wave height 
can be estimated. The process begins with deriving the equations to calculate the required 
collision energy to achieve a specific level of ion dissociation. By isolating the linear 
portion of a % dissociation curve in Figure 4.1 and perform a linear regression analysis, 
the corresponding equation is derived. After working out all the required collision 
energies to achieve the same level of ion dissociation with different wave heights, the 
differences in the required collision energies are good approximation for the changes in 
the total internal energy of ions. This is due to the facts that the ion of interest has only 
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one single electrical charge, and the ion collision in the Transfer cell is the result of 
adjusting the Transfer collision energy, which is the voltage being applied to the entrance 
of the Transfer cell. This, in turn, changes the potential difference between the exit of the 
ion mobility cell and the entrance of the Transfer cell. When the ions exit from the ion 
mobility cell, the electrical energy is applied to the ions, which is then converted into the 
kinetic energy of the ions. While the pressure of Argon gas inside the Transfer cell 
remains constant, the ions collide with the Argon gas and the ion fragmentation occurs. 
Thus, the difference in the required collision energies to achieve the same level of 
ion dissociation under two different settings of wave height is a good approximation for 
the variation on the total internal energy of ions which results from changing the wave 
height. For example, at the level of 50% ion dissociation, changing the wave height from 
40V to 10V, the total internal energy of the selected precursor ion was calculated to be 
9.0eV lower. The other variations in the total internal energy of ions from changing the 
wave height are shown in Table 1. This information is applicable for setting up and/or 
interpreting the results of MS/MS experiments in the mobility TOF mode. In contrast, 
this information can also be useful to avoid some unwanted conformational change of 
larger molecular ions or ion fragmentation in the mobility TOF mode by simply lowering
 the wave height accordingly. 
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Table 4.1. Extent of Variation of Total Internal Energy of Ions Resulted from Changing 
the Wave Heights Between 10 V and 40 V 
 
 
 
 
4.3.2 Using Different Wave Velocities 
In studying the effects of wave velocity on the total internal energy of ions, the 
wave velocity in the ion mobility cell was either increased or decreased from the default 
setting of 650m/s while all the other parameter settings remained constant including the 
wave height. The range of wave velocity from 250m/s to 1050m/s was evaluated. The 
results are shown in Figure 2A. When the wave velocity was decreased step-by-step from 
1050m/s, the % dissociation curve of the same precursor ion was shifted towards higher 
collision energy, which means more collision energy was required in the Transfer cell to 
achieve the same level of ion dissociation. This, in turn, represents the use of slower 
wave velocity leads to lower total internal energy in the precursor ions. In other words, 
there is a direct proportional relationship between the total internal energy of ions and 
wave velocity.  
Since the total internal energy of ions should be directly related to the temperature 
of ions including its vibrational effective temperature, which as mentioned above was 
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investigated by De Pauw and his associates. According to De Pauw’s finding, there is an 
inverse proportional relationship between the vibrational effective temperature of ions 
and wave velocity, i.e. the opposite to what have been observed in this study (Figure
 4.2.).59  
 
 
 
 
Figure 4.2. AMP Ions % Dissociation Against Transfer Cell Collision Energy at Different 
Wave Velocities  
 
 
 
 
 
 
 
 
 
 
Figure 4.3. Bar Chart Representing the Variation of Drift Time in Milliseconds (ms) of 
the Precursor AMP Ions at Different Wave Velocities 
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To further investigate the relationship between the total internal energy of ions 
and wave velocity, the drift time of the selected precursor ion was measured at different 
wave velocities. The results are shown in Figure 2B. The lower the wave velocity, the 
longer the drift time was measured. These results do comply with the principle of ions 
surfing on the traveling voltage wave that exists inside in the ion mobility cell. If the 
wave travels at a slower velocity, it would take a longer time for ions to travel across the 
ion mobility cell, i.e. longer drift time. Based on the measured drift time, and 
approximating the length of the ion mobility cell to be 0.185 meter, the ion speed of the 
precursor ions while traveling across the ion mobility cell with different wave velocities 
were calculated by using the equation derived by Shvartsburg and Smith as shown 
below.13 
 
 
v2 = 2 vd(TW) s
2 / (s + vd(TW))                             equation 2
 
 
Where v is the ion speed, s is the wave velocity, vd(TW) is the drift velocity which 
is equal to the length of drift cell divide by the drift time of selected ion. In Figure 2B, the 
results of this study show the calculated ion speed increases with increasing wave 
velocity. As De Pauw and his associates had pointed out, the ion speed is a good 
predictor of ion effective temperature.15 If ion speed goes up with increasing wave 
velocity as reported by De Pauw, the ion effective temperature should also go up, which 
in turn increases the total internal energy of ion. Hence, the direct proportional 
relationship between the total internal energy of ions and wave velocity in Figure 2A is 
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confirmed. In summary, the results from using the approach of % dissociation curve to 
evaluate the ion energy do agree with the other finding reported by De Pauw.15 
4.4 Absence of Buffer Gas 
In view of the variation on the total internal energy of ions from varying the wave 
height or wave velocity in the ion mobility cell, the extent of ion heating in the traveling 
wave was investigated by using the same approach of % dissociation curve. In this study, 
the % dissociation curve acquired by using the default settings was considered as a 
reference (Figure 4.3). 
 
 
 
 
Figure 4.4. Extent of Ion Heating Without one of the Buffer Gases in the Traveling Wave 
Ion Mobility Cell of Synapt G2 
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(Helium or Nitrogen) in the ion mobility cell, two additional % dissociation curves were 
acquired, which corresponded to either Helium off or Nitrogen off in Figure 3. In the 
absence of one of the buffer gas in the ion mobility cell, the % dissociation curves are 
shifted to the left-hand side of the default curve which corresponds to the presence of 
both buffer gases. Shifting the % dissociation curve to the left means lower collision 
energy was required to achieve the same level of % dissociation. This, in turn, represents 
the total internal energy of precursor ion was increased when one of the buffer gases in 
the ion mobility cell was absent. This result does comply with the ion heating reported 
before when traveling wave ion mobility mass spectrometry was used.16,17 Thus, the 
approach of using the % dissociation curve to estimate the variation on the total internal 
energy of ion is validated and its applicability is demonstrated in this report. The bigger 
increase in the total internal energy of ions with the absence of Nitrogen buffer gas 
indicates more ion heating occur in the ion mobility cell than in the Helium cell or in the 
absence of Helium gas. Based on the shifting of the % dissociation curves in Figure 3, the 
extent of ion heating as a result of transmitting the ions across the ion mobility cell was 
estimated to be ~11.5 eV. 
4.5 Conclusion 
By making use of the unique and versatile design in the Waters Synapt G2 
instrument, this report demonstrates the feasibility of using a simple yet applicable 
approach to estimate the variation on the total internal energy of ions which results from 
using different settings of the key parameters in the traveling wave ion mobility mass 
spectrometry. There are pros and cons on the results of ion heating when ions are exposed 
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to the traveling wave within the ion mobility cell. If ion dissociation is desirable after the 
ion mobility separation, the ion heating will be helpful. On the other hand, for the 
analysis of larger isobaric ions, the ion heating may lead to conformational changes, 
which will lead to incorrect drift time measurements and sample identification. To 
control the ion heating in the traveling wave ion mobility cell, different parameter 
settings in the ion mobility cell can be used. The developed approach can provide a 
simple way to estimate the extent of changes in ion energy which result from using 
different parameter settings in traveling wave ion mobility mass spectrometry. 
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CHAPTER V 
HIGH PERCENTAGE OF ISOMERIC HUMAN MICRORNAS AND THEIR
ANALYTICAL CHALLENGES 
 
 
Parts of the work presented in this chapter has been published in the journal 
of non-coding RNA as referred as Joseph N. Mwangi, and Norman H. L. Chiu,   
Non- coding RNA 2016, 2(4),13 
 
 
4.1 Introduction  
 
In comparison to the structures of other biopolymers that exist in the living cells, 
ribonucleic acid (RNA) has a smaller set of monomeric units, which consist of four 
ribonucleotides, namely adenosine (A), uridine (U), guanosine (G), and cytidine (C). 
Furthermore, two of the nucleobases are purine and the other two are pyrimidine. Despite 
of this rather simple RNA structure, the biological functions of RNA have continued to 
grow. In order to create the complex RNA functions, single-stranded RNA molecules rely 
on the Watson-Crick base pairing and the intramolecular interactions with the hydroxyl 
group at the 2’ position of each ribonucleotide to generate relatively stable RNA folding. 
To overcome the limitation on having only four canonical ribonucleotides, RNA may 
undergo over 100 different types of RNA modifications, which in turn may induce unique 
RNA structures and/or functions65-72. In general, RNA are categorized by their functions. 
For example, messenger RNA are templates for protein synthesis, whereas transfer RNA  
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convert the genetic codes 73into their corresponding amino acid residues during the 
protein synthesis. Since the discovery of small non-coding microRNA (miR), more than 
2,000 human miR have been identified74-77. Specific miR can post-transcriptionally 
regulate gene expression by binding directly with a messenger RNA, which results in 
either blocking the biosynthesis of corresponding protein or cleaving the messenger RNA 
with the assistance from a protein called Dicer78-81. In both cases, the binding between a 
specific miR and its messenger RNA target does not require 100% complementary base 
matching. This binding mechanism, therefore, allows the same miR to regulate more than 
one specific gene expression. 
Collectively, miR is estimated to regulate as much as ~60% of gene expression in 
our bodies. Many specific miR have been associated to various diseases. In some cases, 
several different miR are reported to be associated with the same disease82-88. Besides 
serving as diagnostic and/or prognosis biomarkers, some miR have also been recognized 
as potential drug targets89-94. To further explore the potentials of miR in medical related 
studies, accurate detection of a specific miR is critical. All the current analytical methods 
for miR detection rely on the ability to distinguish a particular RNA structure, which may 
include its size, nucleotide composition and/or RNA sequence95. Although the structural 
information on human miR have been available for some time, no study on comparing 
their structural similarity has been reported yet. In this report, we determine the extent of 
structural similarity among all the human miR; and discuss its consequence to the 
detection of miR.   
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5.2 Results and Discussion  
5.2.1 Size Distribution of Human MicroRNA 
In the literature, the reported values for the minimum and maximum size of 
mature human miR often vary. Besides the possible errors in the earlier reports, this 
discrepancy could also be due to the ever-expanding list of human miR. Based on the 
information that was available from miRBase on August 2016, an attempt to determine 
the correct minimum and maximum size of human miR was carried out in this study. 
There are in total 2,588 human miR. The size of the mature human miR ranges from 16 
to 28 nucleotides (Figure 1.2).  
This makes the average size of mature human miR to be 22 nucleotides. As 
shown in Figure 1.2, among all the human miR, 44% of them have the same size and 
equal to the average size of 22 nucleotides. Only 16% of mature human miR have the 
size of either smaller or equal to 20 nucleotides. The rest of the human miR are longer 
than 22 nucleotides. The size distribution of human miR explains why the probe-based 
methods, in which a complementary DNA oligo or an analogue is used as a molecule 
probe to recognize a specific miR analyte, is a viable approach for the detection of human 
miR. If an RNA molecule has 20 nucleotides, it theoretically creates 4∧20 or over one 
trillion possibilities for its RNA sequence. In other words, the RNA sequence of each 
human miR is unique in the entire human transcriptome, thus the recognition of a specific 
miR by matching its RNA sequence with a complementary DNA probe should provide 
sufficient specificity. However, in practice, non-specific binding of DNA probe is often 
unavoidable, especially when the size and the annealing position of the DNA probe are 
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fixed by the actual size of miR. If non-specific binding is not eliminated, it will lead to 
false-positive results on the detection of miR. To address this issue, different ways to 
improve the specificity of probe-based methods have been reported96, 97. However, 
similar to many other analytical measurements, the outcome from using any specific 
method to detect miR will partly depend on the sample complexity. To the best of our 
knowledge, there is currently no specific method for isolating only miR from a biological 
sample. The closet purification method that is available for miR research can only 
remove RNA longer than 200 nucleotides from a total RNA sample98, 99. Hence, transfer 
RNA and other types of RNA smaller than 200 nucleotides may co-exist with human miR 
in the same sample. In order to achieve high specificity and accuracy on the detection of 
miR, the information on the similarity of the properties of human miR can be very useful. 
For this reason, the rest of this report focuses on comparing the nucleotide composition 
and RNA sequence of human miR.  
5.3 Isomeric MicroRNA 
If two different RNA molecules have the same size and identical nucleotide 
composition, they would be chemically defined as isomers. It is important to note that an 
acronym called isomiR has been reported in the literature, and it does not refer to 
isomeric miR100. Among all the mature human miR, 1,432 (or 55%) of them are isomeric.
 As shown in the figure below. 
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Figure 5.1. Distribution of Isomeric and Non-Isomeric Human Mature microRNA 
 
  
Among the groups of isomeric miR, the highest number of isomers is 13, and there is 
only one group of 13 isomers. Majority of the human isomeric miR (44%) belong to the 
group of 2 isomers. In total, there are 315 different pairs of isomeric miR. Similar to the 
other types of RNA molecules, the modifications of miR have been reported, which 
include both adenylation and uridylation. The results of those RNA modifications would 
change the RNA sequence of miR, which may then alter the extent of miR isomerism. 
However, due to the lack of information on those RNA modifications in the entire 
collection of human miR, it is beyond the scope of this report to determine and compare 
the various extents of miR isomerism with or without any RNA modifications. 
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Table 5.1. The Largest Group of Structural Isomers Among all the Human microRNAs 
 
 
 
 
5.4 Disease-Associated Isomeric MicroRNA 
Through many studies, a lot of human miR have been associated to diseases. In 
some cases, more than one specific miR is associated to the same disease. For this reason, 
whether the disease-associated miR would co-exist in the same biological sample or not, 
there are needs to measure as many disease-associated miR as possible. For instance, 
higher accuracy can be achieved by measuring a small panel of miR that are associated to 
the same disease. To evaluate the implication of miR isomerism to the detection of 
disease-associated miR, three different disease models were selected. The three selected 
disease models are colorectal cancer, malignant ovarian cancer, and epithelial ovarian 
cancer. Based on the information available from miR2disease database, the total number 
of disease-associated miR in each selected model is different from each other. In 
comparison to the entire collection of human miR, the distribution of isomeric miR in 
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each selected disease model is shown in Figure 3. In the case of colorectal cancer, there 
are 88 miR associated to the disease, and 67% of them are isomeric. In the case of 
malignant ovarian cancer, there are 78 miR associated to the disease and 65% of them 
can be isomeric to other human miR. In the case of epithelial ovarian cancer, there are 47 
miR associated to the disease and 72% of them are isomeric. In comparison to the 55% of 
isomeric miR among all the human miR, the percentage of isomeric miR in the selected 
disease models are significantly higher 
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Figure 5.2. Extent of MicroRNA Isomerism Among Selected Diseases 
 
 
The disease-associated microRNA are divided into three groups according to the 
diseases. The total number of disease-associated microRNA in each group is different - 
epithelial ovarian cancer has 47 microRNA, malignant ovarian cancer has 78 microRNA, 
and colorectal cancer has 88 microRNA. Within each group, microRNA are further 
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categorized by the number of isomers. The overlapping of the bar charts do not represent 
the same microRNA are associated to more than one of the selected diseases.  
5.5 Sequence Similarities Among Isomeric MicroRNA 
The minimum difference between the RNA sequence of two isomeric miR is one 
nucleotide. In Table 5.1, six different pairs of isomeric miR were found to be different by 
only two nucleotides. Although some of their names are very similar, the isomeric miR 
with high sequence similarity in Table 5.1 are encoded by different genes. With the high 
sequence similarities, these isomeric miR are expected to target the same messenger 
RNA. Hence, it is important to accurately determine which particular isomer is 
responsible for a specific post-transcriptional regulation of gene expression
 
 
Table 5.2. Examples of Isomeric Human MicroRNA That Have High Sequence 
Similarities, and their Gene Location Within the Human Genome 
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5.6 Analytical Challenges from Isomeric MicroRNA 
As summarized in Table 5.2, the current analytical methods for detecting miR can 
be divided into three categories. In terms of their analytical performance, each category 
has its pros and cons for the detection of a specific miR  
 
 
Table 5.3. Current Categories of Analytical Methods for Measuring microRNA 
. 
 
 
 
Theoretically, the applications of these analytical methods to differentiate isomeric 
miR are feasible but the outcome may vary. Firstly, there is no doubt the current 
sequencing methods including the next generation sequencing technology can 
differentiate isomeric miR even with high sequence similarities. However, in comparison 
to the other analytical methods, the next generation sequencing technology has the 
highest cost on the consumable materials and the highest demand on data analysis. For 
those analytical methods whose end point measurement involves measuring the mass, the 
molecular mass of isomeric miR are exactly identical, thus mass spectrometry with high 
mass resolution will not be useful for the differentiation of isomeric miR. Recently Biba 
and his co-workers101 had completed an in-depth study on using different 
chromatographic methods to resolve small isomeric RNA molecules with high sequence 
similarities. Their experimental results indicated that there are high probabilities for small 
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isomeric RNA to be co-eluted from a chromatographic column. Hence, the coupling of 
liquid chromatography to mass spectrometry may not provide sufficient resolving power 
to differentiate isomeric miR. Since 100% sequence coverage is not always achievable in 
tandem mass spectrometry of RNA, plus the mass difference between uridine and 
cytidine has only 1 Da, it remains challenging to re-sequence RNA with ≥ 22 nucleotides 
by using tandem mass spectrometry. Hence, there is limitation on using mass 
spectrometric methods to accurately identify or differentiate isomeric miR in a single 
sample. By optimizing the annealing conditions, the probe-based methods should have 
the ability to distinguish two or limited number of isomeric miR, providing the 
differences in the RNA sequence of isomeric miR are not at or near the 5’ or 3’ terminals. 
Also, the size and the annealing position of the DNA probe or its analogue are fixed by 
the actual size of miR.    
5.7. Materials and Methods 
In this study, the RNA sequence of mature human miR and the location of its 
corresponding gene in the human genome were downloaded from the latest version of 
miRBase (miRBase 21) database (http://www.mirbase.org) on August 19th 2015. The 
online Mongo oligo mass calculator v2.06 was used to calculate the nucleotide 
composition of each miR. In-house Excel-based tools were used to determine the size of 
miR and identify isomeric human miR. For the analysis of sequence similarity, MAFFT, 
a multiple sequence alignment tool which was freely accessible online was employed to 
generate the data according to the guidelines for the program.  
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The three models of disease used in this study were randomly chosen based on the 
information available from the miR2Disease database, which is a collaboration between 
Indiana University School of Medicine and the Harbin Institute of Technology102. Before 
analyzing the disease-associated miR data as described above in this section, the 
information of each individual miR was crosschecked with information in the miRBase 
database.  
5.8. Conclusion 
Based on the results of this study, the size of mature human miR ranges from 16 
to 28 nucleotides, which is slightly different from the earlier reports. Among 2,588 
mature human miR, 44% have the same size with 22 nucleotides. Despite of this bias in 
their size distribution, and the limitation of only four canonical ribonucleotides, each 
specific miR still has its own unique RNA sequence among the other RNA molecules in 
the human transcriptome. However, for the first time, we report a high percentage (55%) 
of mature human miR are isomeric. MicroRNA that have the same size and identical 
nucleotide composition are defined as isomeric miR and hereby referred as “SimiR” 
which stands for structural isomers of microRNA. In reference to the whole collection of 
human miR, SimiR have been identified among miR that have been associated to a 
specific disease. Although each SimiR has a unique RNA sequence, some SimiR have 
relative high sequence similarities. Since all the current analytical methods for the 
detection of miR rely on the ability to distinguish a particular RNA structure, SimiR 
poses a new analytical challenge to the current methodologies.  
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CHAPTER VI 
CONCLUSIONS 
 
 
6.1 MALDI Matrix Cluster Ions as Internal Reference  
The study aimed at developing an ion mobility mass spectrometry-based method 
for resolving isomeric modified/unmodified RNA biomarkers. Calibration in ion mobility 
has been an impedance in the sense that there lacks a universal calibrant that can be used 
across different platforms and in different laboratories. MALDI matrices are widely used 
across different ion mobility instrumentations. These matrices are in extension used 
across different laboratories and generate unique trendlines in the 2 D ion mobility plots.  
We therefore investigated the utility of these trendlines as internal reference to selected 
model molecular ions. The method has the potential of being applied on different 
platforms using MALDI as an ionization source. This can enable sharing of data across 
different laboratories and from different instrumentations. The initial models included an 
Auto Inducing Peptide (AIP) and Polyethylene Glycol (PEG). The results of this initial 
studies indicate a variety of the existing MALDI matrices do support the concept 
regardless of the ionization polarity of the compounds. Adopting this proposed reference 
method would promote both inter-laboratory and inter-instrumental sharing of mobility 
data. The routine use of intrinsic MALDI matrices as internal reference in ion mobility 
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will also aid in reduction of false positives in ion mobility measurements thus playing a 
role in improving the reliability of ion mobility instruments and their robustness.  
6.2 Effects of Different Modes of Operations on Total Internal Energy of Ions in 
TWIMS 
There are a variety of research articles describing studies conducted to investigate 
the heating of ions in ion mobility cell of the traveling wave mass spectrometry 
instruments including the Synapt G2 used in this study. However, none of these studies, 
to our knowledge has reported comparison of the internal energy of the ions as they 
transit the instrument from the ion source to the detector specifically with regard to the 
effect the heating has on the dissociation of ions in both operation modes i.e. TOF and 
Mobility TOF modes.   
Using a number of different molecular structure ions, we have done a rather 
comprehensive comparison between the two modes of operation by performing CID in 
Trap and Transfer cells while keeping all other parameters constant. Results obtained 
from these experiments indicate that less CID energy is required to achieve the same 
percentage of dissociation in the Transfer cell when performing the experiments in TOF 
mode. We attribute this to the RF voltage heating of the ions as they traverse through the 
ion mobility cell which operates as an ion guide in TOF mode. 
On the other hand, in ion mobility mode, you need more CID energy in the transfer cell 
to achieve the same percentage dissociation as in the trap cell. When performing CID 
energy in the transfer cell, the ions have traversed the ion mobility cell and collisional 
cooling is purported to have occurred such that the ions have less total internal energy 
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when in the Transfer cell. To investigate the role of the gases in the total internal energy 
of the ions, the gases were sequentially turned off and CID performed in the transfer cell. 
Results indicate that in the absence of either of the gases, total internal energy of the ions 
increases thus requiring less CID energy to achieve the same percentage dissociation.  
There were no software or instrument modifications/adjustments available to make the 
ion residence time both in the Trap and Transfer similar in order for the two collision 
cells % dissociation to be completely comparable, however, the wave velocity set as 
default for the Transfer cell was relatively low i.e. 150 m/s and would decrease the 
resident time compared to Trap’s 250 m/s which by default has a prolonged trap time as 
ions accumulate in readiness for release into the IMS cell. The results obtained, and 
conclusion hereby drawn is with an assumption that the difference in residence time for 
the two cells was not significant enough to cause any significance difference observed in 
the probe ions used.  
6.3 Extent of Isomerism in Human MicroRNA Biomarkers and Their Challenges 
Thereof 
Recently, microRNAs have generated a lot of interest since their expression is 
associated with various types of diseases including different types of cancers. Their 
availability in body fluids including saliva has been touted as a possible minimally 
invasive diagnostic approach. Since they are small in size, they are expected to be similar 
in structure. However, the extent of their similarities had not been explored or reported. 
Our publication has shed light on how similar these important biomolecules can be and 
the challenges to both current and new analytical methods designed to analyze them. The 
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knowledge of the extent of isomerism and the number of SimiRs in the currently reported 
human microRNAs will assist researchers who aim to get a deep insight in their 
functions.  
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